Logo image of BYL.CA

BAYLIN TECHNOLOGIES INC (BYL.CA) Stock Fundamental Analysis

TSX:BYL - Toronto Stock Exchange - CA0728191051 - Common Stock - Currency: CAD

0.215  +0.01 (+2.38%)

Fundamental Rating

2

Overall BYL gets a fundamental rating of 2 out of 10. We evaluated BYL against 3 industry peers in the Electronic Equipment, Instruments & Components industry. BYL has a bad profitability rating. Also its financial health evaluation is rather negative. BYL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BYL had negative earnings in the past year.
In the past year BYL had a positive cash flow from operations.
BYL had negative earnings in each of the past 5 years.
In multiple years BYL reported negative operating cash flow during the last 5 years.
BYL.CA Yearly Net Income VS EBIT VS OCF VS FCFBYL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

BYL has a Return On Assets (-15.07%) which is in line with its industry peers.
Industry RankSector Rank
ROA -15.07%
ROE N/A
ROIC N/A
ROA(3y)-20.62%
ROA(5y)-29.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BYL.CA Yearly ROA, ROE, ROICBYL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K 20K 30K

1.3 Margins

Looking at the Gross Margin, with a value of 42.08%, BYL is in line with its industry, outperforming 60.00% of the companies in the same industry.
BYL's Gross Margin has improved in the last couple of years.
BYL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.78%
GM growth 5Y2.81%
BYL.CA Yearly Profit, Operating, Gross MarginsBYL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

BYL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BYL has been increased compared to 1 year ago.
The number of shares outstanding for BYL has been increased compared to 5 years ago.
Compared to 1 year ago, BYL has a worse debt to assets ratio.
BYL.CA Yearly Shares OutstandingBYL.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BYL.CA Yearly Total Debt VS Total AssetsBYL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -4.66, we must say that BYL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -4.66, BYL is doing worse than 80.00% of the companies in the same industry.
The Debt to FCF ratio of BYL is 5.56, which is a neutral value as it means it would take BYL, 5.56 years of fcf income to pay off all of its debts.
BYL's Debt to FCF ratio of 5.56 is fine compared to the rest of the industry. BYL outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.56
Altman-Z -4.66
ROIC/WACCN/A
WACC7.99%
BYL.CA Yearly LT Debt VS Equity VS FCFBYL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.80 indicates that BYL may have some problems paying its short term obligations.
The Current ratio of BYL (0.80) is worse than 80.00% of its industry peers.
BYL has a Quick Ratio of 0.80. This is a bad value and indicates that BYL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.46, BYL is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.46
BYL.CA Yearly Current Assets VS Current LiabilitesBYL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.98% over the past year.
The Revenue for BYL has decreased by -41.93% in the past year. This is quite bad
BYL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.42% yearly.
EPS 1Y (TTM)88.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.05%
Revenue 1Y (TTM)-41.93%
Revenue growth 3Y-6.57%
Revenue growth 5Y-11.42%
Sales Q2Q%-5.92%

3.2 Future

BYL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.48% yearly.
Based on estimates for the next years, BYL will show a small growth in Revenue. The Revenue will grow by 1.73% on average per year.
EPS Next Y25%
EPS Next 2Y27.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.32%
Revenue Next 2Y1.73%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BYL.CA Yearly Revenue VS EstimatesBYL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
BYL.CA Yearly EPS VS EstimatesBYL.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

BYL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BYL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYL.CA Price Earnings VS Forward Price EarningsBYL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

73.33% of the companies in the same industry are more expensive than BYL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, BYL is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.67
EV/EBITDA 42.84
BYL.CA Per share dataBYL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

BYL's earnings are expected to grow with 27.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.48%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BYL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAYLIN TECHNOLOGIES INC

TSX:BYL (6/13/2025, 7:00:00 PM)

0.215

+0.01 (+2.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-05 2025-08-05
Inst Owners0.61%
Inst Owner ChangeN/A
Ins Owners1.87%
Ins Owner ChangeN/A
Market Cap32.59M
Analysts76.67
Price Target0.36 (67.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.67%
PT rev (3m)-30%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-100%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF 5.67
P/OCF 5.6
P/B N/A
P/tB N/A
EV/EBITDA 42.84
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.04
FCFY17.64%
OCF(TTM)0.04
OCFY17.87%
SpS0.54
BVpS-0.07
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.08%
FCFM 6.97%
ROA(3y)-20.62%
ROA(5y)-29.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.78%
GM growth 5Y2.81%
F-Score4
Asset Turnover1.74
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.56
Debt/EBITDA 33.09
Cap/Depr 2.93%
Cap/Sales 0.09%
Interest Coverage N/A
Cash Conversion 620.23%
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.46
Altman-Z -4.66
F-Score4
WACC7.99%
ROIC/WACCN/A
Cap/Depr(3y)11.25%
Cap/Depr(5y)21.99%
Cap/Sales(3y)0.89%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.05%
EPS Next Y25%
EPS Next 2Y27.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-41.93%
Revenue growth 3Y-6.57%
Revenue growth 5Y-11.42%
Sales Q2Q%-5.92%
Revenue Next Year-4.32%
Revenue Next 2Y1.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y88.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year310.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y470.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1768.77%
OCF growth 3YN/A
OCF growth 5YN/A